Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Weight Loss 2Polyps 2Hyperplasia 2Stomach Neoplasms 1Psoriasis 1Osteoarthritis 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myeloid, Chronic-Phase 1Colitis, Ulcerative 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Cachexia 1Cachexia 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Anorexia 1Adenomatous Polyps 1Adenomatous Polyposis Coli 1

Interventions

Colonoscopy 5Cholecalciferol 3Aspirin 3Selenium 2Narrow Band Imaging 2Calcium Carbonate 2alpha-Tocopherol 1Walking 1Vitamin E 1Ursodeoxycholic Acid 1Rosuvastatin Calcium 1Restraint, Physical 1Occult Blood 1Metformin 1Folic Acid 1Fluorescein 1Erlotinib Hydrochloride 1Endoscopy 1Eicosapentaenoic Acid 1Eflornithine 1Diarylheptanoids 1Contraceptive Devices, Female 1Colonography, Computed Tomographic 1Clinical Chemistry Tests 1Celecoxib 1Calcium 1Calcitriol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Adenomatous Polyps × Eicosapentaenoic Acid × Clear all
NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡